News & Updates
Filter by Specialty:
Pituitary TF–based classification improves diagnostic accuracy and prognostication of nonfunctioning PitNETs
Utility of pituitary transcription factors (TFs) improves the diagnostic accuracy and prognostication of nonfunctioning pituitary neuroendocrine tumours (NF-PitNETs), according to local data and a new diagnostic classification presented at the 5th Annual Meeting of Endocrinology, Diabetes & Metabolism Hong Kong (EDM HK).
Pituitary TF–based classification improves diagnostic accuracy and prognostication of nonfunctioning PitNETs
30 Nov 2022
Low-carb vegan diet reduces weight, greenhouse gas emissions
Vegan and vegetarian diets that are low in carbohydrates reduce body weight as well as improve glycaemic control and blood pressure in individuals with type 2 diabetes (T2D), suggests a study, adding that a plant-based diet shows greater potential decrease in greenhouse gas emissions.
Low-carb vegan diet reduces weight, greenhouse gas emissions
23 Nov 2022
GLP-1 receptor agonists halt COPD exacerbations in T2D patients
Use of glucagon-like peptide 1 (GLP-1) receptor agonists or sodium-glucose co-transporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, helps prevent severe exacerbations of chronic obstructive pulmonary disease (COPD) in patients with type 2 diabetes (T2D), a UK study has shown.
GLP-1 receptor agonists halt COPD exacerbations in T2D patients
23 Nov 2022
Adjunctive semaglutide yields additional weight loss in teens with obesity
Once-weekly treatment with semaglutide, when administered with lifestyle intervention, leads to greater reduction in body mass index among adolescents with obesity as compared with lifestyle intervention alone, as shown in the STEP TEENS study.
